Sradha Kotwal's Publications
About Sradha Kotwal's Publications
Program Head, Renal and Metabolic Division-
Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD
Kidney International Reports Date published: -
Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial
Diabetes, Obesity and Metabolism Date published: -
Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial
Nephrology Dialysis Transplantation Date published: -
Effects of Semaglutide on CKD in Patients With Type 2 Diabetes
Kidney International Reports Date published: -
Risk factors associated with 30-day mortality following COVID -19 infection in patients receiving kidney replacement therapy in Australia and New Zealand
Internal Medicine Journal Date published: -
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial
Diabetes, Obesity and Metabolism Date published: -
Glomerular Disease Registry and Biobank: Baseline and Follow-Up Results
Date published: -
Baseline Characteristics of ASSIST: Phase 2 Crossover Trial of Atrasentan in Adults with IgAN on SGLT2 Inhibitors
Date published: -
A K-ritical Review: Safety of Potassium Intake in CKD: A Systematic Review and Synthesis Without Meta-Analysis (SWiM)
Date published: -
Incidence of CKD in Australian Primary Care: Analysis of a National Primary Care Dataset
Date published: -
Sex-Related Differences in CKD Monitoring and Cardiovascular Risk Management in Australian Primary Care: A Retrospective Cohort Study
Date published: -
Variability in eGFR and Adverse Kidney Outcomes in Routine Clinical Practice
Date published: -
Eye on AKI: Are Shifting Trends the Cue for a Platform Clinical Trial?
Journal of the American Society of Nephrology Date published: -
The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design
JAMA Network Open Date published: -
Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis
Journal of the American Society of Nephrology Date published: -
Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial
BMJ Open Date published: